- Home
- MYFW vs CRBP Comparison
MYFW vs CRBP Comparison
Compare MYFW & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- CRBP
- Stock Information
- Founded
- MYFW 2002
- CRBP 2009
- Country
- MYFW United States
- CRBP United States
- Employees
- MYFW N/A
- CRBP N/A
- Industry
- MYFW Major Banks
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- CRBP Health Care
- Exchange
- MYFW Nasdaq
- CRBP Nasdaq
- Market Cap
- MYFW 198.1M
- CRBP 227.3M
- IPO Year
- MYFW 2018
- CRBP N/A
- Fundamental
- Price
- MYFW $20.82
- CRBP $16.73
- Analyst Decision
- MYFW Buy
- CRBP Strong Buy
- Analyst Count
- MYFW 3
- CRBP 7
- Target Price
- MYFW $21.33
- CRBP $65.86
- AVG Volume (30 Days)
- MYFW 45.3K
- CRBP 346.4K
- Earning Date
- MYFW 10-24-2024
- CRBP 11-07-2024
- Dividend Yield
- MYFW N/A
- CRBP N/A
- EPS Growth
- MYFW N/A
- CRBP N/A
- EPS
- MYFW 0.26
- CRBP N/A
- Revenue
- MYFW $79,649,000.00
- CRBP N/A
- Revenue This Year
- MYFW N/A
- CRBP N/A
- Revenue Next Year
- MYFW $13.44
- CRBP N/A
- P/E Ratio
- MYFW $79.71
- CRBP N/A
- Revenue Growth
- MYFW N/A
- CRBP N/A
- 52 Week Low
- MYFW $12.84
- CRBP $4.00
- 52 Week High
- MYFW $21.87
- CRBP $61.90
- Technical
- Relative Strength Index (RSI)
- MYFW 59.42
- CRBP 37.25
- Support Level
- MYFW $20.40
- CRBP $15.65
- Resistance Level
- MYFW $20.77
- CRBP $17.18
- Average True Range (ATR)
- MYFW 0.66
- CRBP 1.26
- MACD
- MYFW 0.07
- CRBP 0.35
- Stochastic Oscillator
- MYFW 84.37
- CRBP 21.09
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.